Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Biopharmaceutical company developing novel cancer immunotherapy products.
ImmuneOnco Biopharma has raised $25.0M across 1 funding round.
ImmuneOnco Biopharma has raised $25.0M in total across 1 funding round.
ImmuneOnco Biopharma has raised $25.0M in total across 1 funding round.
ImmuneOnco Biopharma's investors include Lilly Asia Ventures, LiCheng Asset, LYFE Capital.
ImmuneOnco Biopharma has raised $25.0M across 1 funding round. Most recently, it raised $25.0M Series B in October 2020.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 10, 2020 | $25M Series B | Lilly Asia Ventures | LiCheng Asset, Lyfe Capital | Announced |